Search the Site

Twitter

test tubes

This Week's Watchlist 12/13/10

publication date: Dec 11, 2010
CPIX - The PDUFA date for CPIX was on Friday, with no announcement from the company in after hours.  If the FDA is on time we would expect to hear an annoucement on Monday or Tuesday.  Shares of CPPIX have already climbed over 74% from its September lows in the mid $4 range.  

OREX - Last week was a rollercoaster ride for those in OREX, as the price spike to over $12 in after hours trading after the FDA Advisory Panel recommended Contrave for approval. This euphoria quickly began to fade, as shares closed the week in the mid $8 range, as the reality of an uphill battle with the FDA settled in.

MNKD - Shares of MannKind surged last week, demonstarting that the run-up is still alive for this company and its inhailable insulin. Share prices have climbed over 40% from just one month ago.  

DEPO - While other run-ups have demonstrated increased volitity, there is one 'slow and steady' player in the game, and it is DEPO- which has climbed over 110% since this July.  On Thursday of last week, DEPO set its 52-week high, and it shows no sign of slowing. Volume and interest in this FDA play (PDUFA date 1/30/11).